Qiagen N.V.
Qiagen N.V. Fundamental Analysis
Qiagen N.V. (QGEN) shows moderate financial fundamentals with a PE ratio of 23.30, profit margin of 20.33%, and ROE of 11.85%. The company generates $2.1B in annual revenue with weak year-over-year growth of 0.66%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 56.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze QGEN's fundamental strength across five key dimensions:
Efficiency Score
WeakQGEN struggles to generate sufficient returns from assets.
Valuation Score
ModerateQGEN shows balanced valuation metrics.
Growth Score
WeakQGEN faces weak or negative growth trends.
Financial Health Score
ExcellentQGEN maintains a strong and stable balance sheet.
Profitability Score
ModerateQGEN maintains healthy but balanced margins.
Key Financial Metrics
Is QGEN Expensive or Cheap?
P/E Ratio
QGEN trades at 23.30 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, QGEN's PEG of 3.96 indicates potential overvaluation.
Price to Book
The market values Qiagen N.V. at 2.62 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.55 times EBITDA. This signals the market has high growth expectations.
How Well Does QGEN Make Money?
Net Profit Margin
For every $100 in sales, Qiagen N.V. keeps $20.33 as profit after all expenses.
Operating Margin
Core operations generate 24.90 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.85 in profit for every $100 of shareholder equity.
ROA
Qiagen N.V. generates $6.75 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Qiagen N.V. generates strong operating cash flow of $648.77M, reflecting robust business health.
Free Cash Flow
Qiagen N.V. generates strong free cash flow of $448.79M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.18 in free cash annually.
FCF Yield
QGEN converts 4.63% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
23.30
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
3.96
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.62
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.70
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.44
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.90
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How QGEN Stacks Against Its Sector Peers
| Metric | QGEN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 23.30 | 29.28 | Better (Cheaper) |
| ROE | 11.85% | 820.00% | Weak |
| Net Margin | 20.33% | -19743.00% (disorted) | Strong |
| Debt/Equity | 0.44 | 0.26 | Weak (High Leverage) |
| Current Ratio | 3.90 | 4.69 | Strong Liquidity |
| ROA | 6.75% | -17807.00% (disorted) | Weak |
QGEN outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Qiagen N.V.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
31.72%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
304.94%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
106.91%
Industry Style: Defensive, Growth, Innovation
High Growth